Zydus Cadila has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASH in India, the drug major said on Thursday. The Ahmedabad-based company said the approved product is the first ever drug anywhere in the world…